Literature DB >> 3429508

Analysis of platinum species originating from cis-diamminedichloroplatinum(II) (cisplatin) in human and rat plasma by high-performance liquid chromatography with on-line inductively coupled plasma atomic emission spectrometric detection.

W A de Waal1, F J Maessen, J C Kraak.   

Abstract

The applicability of reversed-phase ion-pair chromatography with on-line inductively coupled plasma atomic emission spectrometric detection was investigated for the analysis of cisplatin, its hydrolysis products and two methionine-platinum complexes in aqueous solutions. The detector response for cisplatin was linear over three orders of magnitude. The detection limit was found to be 3.5 ng, corresponding to a concentration detection limit of 35 ng/ml. The ion-pair system developed was applied to the analysis of (bio)transformation products originating from cisplatin in human and rat plasma in vitro and in vivo. In vitro, a number of platinum-containing species are formed, two of which show the same retention as the mono- and diaqua hydrolysis products of cisplatin. Preliminary results for in vivo experiments indicate cisplatin to be the predominant species in rat plasma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3429508     DOI: 10.1016/s0021-9673(01)92623-8

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

Review 1.  Platinum antitumour agents: a review of (bio)analysis.

Authors:  T J Hodes; W J Underberg; G Los; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

2.  Carboplatin-Complexed and cRGD-Conjugated Unimolecular Nanoparticles for Targeted Ovarian Cancer Therapy.

Authors:  Yuyuan Wang; Liwei Wang; Guojun Chen; Shaoqin Gong
Journal:  Macromol Biosci       Date:  2016-12-01       Impact factor: 4.979

3.  Pressure tuning infrared spectroscopic study of cisplatin-induced structural changes in a phosphatidylserine model membrane.

Authors:  K D Taylor; R Goel; F H Shirazi; M Molepo; P Popovic; D J Stewart; P T Wong
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.